Inside Lyme Podcast with Dr. Daniel Cameron

👉 Have you faced delays in Lyme disease treatment? Comment below.

Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma.

The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and manageable, while the risks of inaction include permanent neurologic damage, arthritis, cardiac issues, and even death.

The path forward lies in shared decision-making, individualized care, and supporting physicians so they feel safe providing thoughtful, evidence-based treatment. Ultimately, patient welfare must come before professional hesitation.

#LymeDisease #LymeWarrior #ChronicLyme #LymeAwareness #PatientStories

👉 Have you faced delays in Lyme disease treatment? Comment below.

Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma.

The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and manageable, while the risks of inaction include permanent neurologic damage, arthritis, cardiac issues, and even death.

The path forward lies in shared decision-making, individualized care, and supporting physicians so they feel safe providing thoughtful, evidence-based treatment. Ultimately, patient welfare must come before professional hesitation.

#LymeDisease #LymeWarrior #ChronicLyme #LymeAwareness #PatientStories

Have you had symptoms return after stopping Lyme treatment? Share your story below. Your experience may help someone else navigating the same difficult decision.

Summary

One of the most frequent questions in Lyme care is: “If I feel better, should I stop treatment?” The answer is complicated. While no one wants to stay on antibiotics longer than necessary, stopping too soon often leads to relapse.

Lyme disease is not a typical infection. Borrelia burgdorferi can persist by hiding in tissues, forming biofilms, and shifting into alternate forms. When treatment ends prematurely, surviving bacteria may re-emerge, and symptoms such as brain fog, joint pain, fatigue, or neuropathy often return. Co-infections like Babesia or Bartonella add another layer, sometimes becoming more obvious once Lyme therapy is withdrawn.

Guidelines remain divided. IDSA discourages extended therapy, while ILADS—where I helped author the 2004 and 2014 guidelines—supports individualized, carefully monitored treatment when patients remain ill. The key is shared decision-making, weighing risks and benefits, and avoiding a one-size-fits-all approach.

The goal is not indefinite treatment, but the minimum effective therapy that allows patients to heal and reclaim their lives. The takeaway is simple: stopping Lyme treatment too soon often means starting over. Recovery is about staying better tomorrow—not just feeling better today.

Treating Lyme disease in elderly patients is one of the most complex challenges I see in my practice.

Unlike younger adults, older patients often live with multiple health conditions. They may be taking many medications, which raises the risk of drug interactions. Kidney or liver function may be reduced, making it harder to clear antibiotics. And neurological symptoms from Lyme can increase the risk of falls, which can have devastating consequences in this age group.

Standard guidelines don’t always address these realities. What works well for a younger patient may not be safe—or effective—for someone in their eighties. That’s why Lyme disease treatment in elderly patients requires individualized care.

Every decision has to balance infection control with age-related vulnerabilities. Antibiotics may be necessary, but they can also increase risks like dehydration, C. difficile infection, or secondary complications. Medications for neuropathy may relieve pain but could also cause sedation and falls. And we can’t overlook the role of co-infections like Babesia or Bartonella, which make recovery even more complicated.

As an ILADS guideline author, I’ve emphasized the importance of clinical judgment and patient-centered care. For elderly patients, that means more frequent monitoring, lower starting doses, and close coordination with family and caregivers. The goal isn’t just to fight infection—it’s to preserve function, independence, and quality of life.

So here’s the bottom line: elderly Lyme disease patients need more than standard protocols. They need individualized care that takes into account the whole person, not just the infection.”

“Has your family faced challenges with Lyme disease treatment for kids? Share your story in the comments—because until children are included in research, parents’ voices are one of the most powerful tools we have. 
.
.
No NIH-funded Lyme treatment trials have included children under 18. Yet kids often present differently than adults—showing fatigue, mood or school changes, rather than joint pain. Their developing immune and nervous systems also process infection and medication uniquely.

Because guidelines rely on adult data, children risk being dismissed or undertreated. Some relapse if therapy ends too soon, while others improve only when co-infections are addressed.

Bottom line: pediatric Lyme requires individualized, flexible care until research finally includes children.
.
.
#LymeDisease #LymeTreatment #PediatricLyme #LymeAwareness #ChildHealth #LymeWarrior #ChronicLyme #InvisibleIllness #ParentVoices

Have you experienced gaslighting in your Lyme journey? Drop your story below—your voice can help others feel less alone.
.
.
Summary
Many Lyme disease patients experience medical gaslighting—dismissive comments like “your labs are normal” or “the treatment is finished”—even while symptoms like fatigue, brain fog, pain, and neuropathy persist. This erodes trust, adds psychological harm, and often drives patients toward alternative medicine, not out of rejection of science but in search of time, holistic care, ongoing support, and validation.

The solution isn’t to push patients away, but to listen, explain uncertainties, stay connected, and collaborate when integrative care is sought. At its core, Lyme patient gaslighting is both a medical and ethical failure. Patients deserve to be believed and supported.

I’m Dr. Daniel Cameron. In my practice, I often see patients with chronic pain, and I want to explore whether chronic Lyme disease could be part of the puzzle behind America’s growing pain epidemic.

A recent paper by Jovkovich in Pain reported that chronic pain prevalence in U.S. adults rose from 21% in 2019 to 24% in 2023—affecting 60 million people. Only about 13% of this increase was linked to long COVID. The rest remains unexplained.

Overlap Between Lyme Pain and National Pain Trends

The types of pain described—back, neck, joint, headache, abdominal, and widespread musculoskeletal pain—mirror what I see in chronic Lyme patients. Lyme pain is often multi-system, migratory, unpredictable, and can flare with fatigue and stress. It includes:

Musculoskeletal pain: Joint and tendon pain, often misdiagnosed as fibromyalgia.

Neurologic pain: Headaches resistant to migraine therapy, burning or electrical-shock sensations, small fiber neuropathy.

Abdominal/pelvic pain: Frequently linked with autonomic dysfunction.

Why Lyme Gets Missed

Testing limitations: Standard CDC two-tier testing is more reliable in acute cases, leaving many chronic patients without positive results.

Mislabels: Fibromyalgia, chronic fatigue syndrome, or “pain of unknown origin.”

COVID-era factors: More outdoor exposure, missed diagnoses due to care delays, absent rash or visible tick bite.

Geography and Demographics

The pain hotspots in the Pain study—Northeast, Upper Midwest, Pacific coast—are also Lyme-endemic regions. Affected populations included working adults, outdoor enthusiasts, rural and suburban residents, aligning closely with Lyme risk groups.

Strongest Evidence: Treatment Response

Perhaps the clearest sign is clinical: when patients with undiagnosed Lyme receive targeted antibiotic or co-infection therapy, their chronic pain often improves or resolves.

Bottom line: Chronic Lyme disease may be an overlooked contributor to America’s pain crisis. The symptoms overlap, the geography matches, and patients often respond to treatment. To better address the 60 million Americans in pain, we need to update diagnostic strategies, look beyond tick rash and positive tests, and include Lyme disease in the differential.

Welcome. Here are ten practical tips for Healthcare Providers to prevent chronic Lyme disease.

1. Lyme Disease is Primarily a Clinical Diagnosis

 • While laboratory tests, like the two-tiered approach of ELISA followed by Western blot, can provide valuable support, Lyme disease diagnosis hinges on clinical judgment. The disease’s early symptoms, such as the classic erythema migrans rash, fever, and joint pain, often present before the immune system has generated detectable antibodies. This means that the diagnosis is often made based on clinical presentation, particularly in endemic areas, even if tests are negative.

2. Early Treatment Can Prevent Complications

 • The importance of early treatment in Lyme disease cannot be overstated. Studies have consistently shown that when antibiotics are administered promptly—ideally within weeks of infection—they can prevent the progression to more serious complications, such as Lyme arthritis, neuroborreliosis, and Lyme carditis. The window for optimal intervention is narrow, making early recognition and treatment vital.

3. Co-Infections Are Common and Complicate the Picture

 • Ticks don’t just carry Borrelia burgdorferi; they can also transmit other pathogens like Babesia microti, Bartonella henselae, and Anaplasma phagocytophilum. These co-infections can lead to overlapping or more severe symptoms and may require different or additional treatments. Research indicates that co-infections are present in up to 30% of Lyme disease cases, which underscores the importance of considering a broad differential diagnosis when symptoms persist.

4. Lyme Disease Can Mimic a Range of Other Conditions

 • Known as "The Great Imitator," Lyme disease can present with symptoms that resemble those of multiple sclerosis, rheumatoid arthritis, fibromyalgia, or chronic fatigue syndrome. This mimicry can lead to misdiagnoses, delaying proper treatment. It’s crucial for healthcare providers to consider Lyme disease in their differential diagnosis, especially in patients with a history of tick exposure.

5. Seronegative Lyme Disease is a Real and Recognized Phenomenon

 • Not all patients with Lyme disease will test positive on standard serologic tests, especially in the early stages or if they have received early antibiotic treatment. This phenomenon, known as seronegative Lyme disease, can make diagnosis challenging. Clinical studies suggest that up to 20-30% of early Lyme disease cases may be seronegative, which requires healthcare providers to rely on their clinical instincts and patient history.

6. Post-Treatment Lyme Disease Syndrome (PTLDS) Requires Attention

 • PTLDS, affecting 10-20% of Lyme disease patients, presents a significant challenge. Symptoms like fatigue, pain, and cognitive difficulties persist long after the infection should have been cleared. The exact cause of PTLDS is still debated, with theories ranging from persistent infection to autoimmune dysfunction. What is clear, however, is that these patients need careful management and support, rather than dismissal.

7. Prevention Through Tick Avoidance is Key

 • Preventing tick bites is the most effective strategy to avoid Lyme disease and its associated complications. This includes the use of insect repellents, wearing protective clothing, performing regular tick checks, and removing ticks promptly. Education about these preventive measures is essential, particularly in areas where Lyme disease is endemic.

8. Rash is Not Always Present, but It’s a Strong Indicator

9. Lyme Disease is Expanding Beyond Traditional Regions

10. Lyme Disease Can Affect Multiple Organ Systems

I'm Dr. Daniel Cameron, and today I’m addressing a question I often see in my practice: What are the risk factors for chronic Lyme disease?

Chronic Lyme Symptoms

Some patients do not fully recover from Lyme disease. They experience a broad range of symptoms, including ongoing fatigue, pain, sleep problems, neurologic changes, emotional strain, and disruption of daily life. These challenges can affect school, parenting, and work responsibilities.

Common chronic Lyme manifestations include:

Musculoskeletal: chronic arthritis, muscle pain, stiffness, and tendon inflammation.

Neurologic and psychiatric: brain fog, memory issues, neuropathy, sensory changes, depression, irritability, mood swings, and PANS. Post-treatment Lyme disease syndrome (PTLDS) is often debated, but I view it as a potential ongoing infection rather than simply a syndrome.

Cardiovascular/dysautonomia: POTS, Lyme carditis, arrhythmias, chest pain, and dizziness.

Other manifestations: sensory overload (light, sound, heat, cold, or smell sensitivity), sometimes related to dysautonomic issues.

Risk Factors for Chronic Lyme Disease

While formal assessments are ongoing, in my practice I see several consistent contributors:

Severe initial infection such as neurologic Lyme meningitis or carditis.

Treatment delays, sometimes months or years.

Early systemic involvement at onset—widespread fatigue, pain, neurological symptoms, or functional loss.

Co-infections such as Babesia and other tick-borne pathogens.

Reinfections and relapses, which can increase the likelihood of chronic complications.

Key Takeaways for Clinicians

Screen patients carefully for these risk factors.

Monitor for co-infections, especially in high-risk or relapsing patients.

Do not dismiss persistent symptoms, even if a formal diagnosis has not yet been established.

Advice for Patients

Seek early treatment—timing matters.

If symptoms persist, pursue a second opinion or find a physician experienced in managing chronic manifestations of Lyme disease.

Watch for co-infections, especially Babesia, which may complicate recovery and even mimic other conditions (e.g., menopause).

Advocate for comprehensive care for yourself and your family.

Thank you for joining me. Please leave your questions and comments below—I read them all and respond where I can.

Lyme and PANS: A Critical Connection in Teenagers

At just 16, my patient found herself facing a complex and overwhelming set of symptoms. What began as ordinary teenage stress evolved into something far more debilitating—raging outbursts, severe compulsions, motor and vocal tics, and memory problems. Her academic performance plummeted, and her social life disintegrated. Diagnosed with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), she and her family embarked on a challenging journey for answers.

PANS, a condition characterized by the sudden onset of severe neuropsychiatric symptoms, is often triggered by infections or autoimmune responses. These symptoms include obsessive-compulsive behaviors, severe anxiety, and a wide array of neurological issues. In my patient's case, the impact was profound, disrupting nearly every aspect of her life.

A Frustrating Treatment Journey

Her school quickly implemented a 504 plan to accommodate her needs, but even with these supports, she struggled to attend classes regularly. The academic gaps widened, and the isolation grew. Initially, her treatment focused on intravenous immunoglobulin (IVIG) therapy, a standard approach for PANS aimed at modulating the immune system. Unfortunately, despite several courses of IVIG, her symptoms persisted, leading to a sense of despair for both her and her family.

The Lyme Disease Connection

It wasn’t until the family explored further that they discovered a potential link between Lyme disease and PANS. Lyme disease, transmitted by ticks and caused by the Borrelia burgdorferi bacterium, is notorious for its wide range of symptoms, many of which can overlap with neuropsychiatric disorders. When Lyme disease enters the picture, it can trigger or exacerbate PANS, leading to an even more complicated clinical scenario.

Upon testing, my patient was diagnosed with Lyme disease and a co-infection, which had gone undetected. The realization that these infections were contributing to her PANS symptoms was a breakthrough. She began antibiotic therapy, which is often essential in treating Lyme disease, especially when co-infections are involved. Over time, this approach started to pay off—her symptoms gradually improved, the rage outbursts and compulsions became less frequent, and her cognitive function began to recover.